This inventor holds 1 USPTO granted patent and 6 published patent applications and 2 EPO patents. Top assignees: Centaurus Biopharma Co., Ltd., Chia Tai Tianqing Pharmaceutical Group Co., Ltd., Lianyungang Runzhong Pharmaceutical Co., Ltd.. Active years: 2021.
Company Filing History:
1 out of 33 
1 out of 121 
1 out of 26 Years Active: 2021
Title: The Innovations of Hongjuan Li
Introduction
Hongjuan Li is a prominent inventor based in Beijing, China. She has made significant contributions to the field of pharmaceuticals, particularly in the development of innovative compounds. Her work focuses on creating solutions that address critical health issues.
Latest Patents
Hongjuan Li holds 1 patent for her invention titled "Macrocycle containing aminopyrazole and pyrimidine and pharmaceutical composition and use thereof." This patent relates to a macrocycle that includes aminopyrazole and pyrimidine, which is designed to inhibit tropomyosin receptor kinase (Trk) activity. The invention aims to treat diseases in mammals that are mediated by Trk, showcasing her commitment to advancing medical science.
Career Highlights
Throughout her career, Hongjuan Li has worked with notable companies in the pharmaceutical industry. She has been associated with Chia Tai Tianqing Pharmaceutical Group Co., Ltd. and Centaurus Biopharma Co., Ltd. These experiences have allowed her to apply her innovative ideas in practical settings, contributing to the development of new therapies.
Collaborations
Hongjuan Li has collaborated with esteemed colleagues, including Liguang Dai and Xiaowei Duan. These partnerships have fostered a collaborative environment that enhances the research and development of new pharmaceutical solutions.
Conclusion
Hongjuan Li's contributions to the field of pharmaceuticals through her innovative patent and collaborations highlight her role as a leading inventor. Her work continues to impact the medical community positively.